Introduction {#sec1}
============

Heteroarenes are essential substructures of a large proportion of small-molecule drugs, functionalization of which is of paramount importance for the design and synthesis of pharmaceutical targets^[@ref1]^ and natural products.^[@ref2]^ Pioneering work by Minisci, known as Minisci reactions, realized the direct C--H acylation and alkylation of heteroarenes with aldehydes^[@cit3f]^ and carboxylic acids,^[@cit3g]^ respectively ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}A). With the development of radical chemistry and photoredox catalysis, Minisci reaction has undergone a remarkable renaissance in the past decade, offering increasingly powerful methods for synthesizing heteroarene-based organic building blocks.^[@ref4],[@ref5]^ Acyl radicals are one of the most important elements;^[@ref6]^ they are conventionally generated by aldehydes to realize Minisci acylation via oxidative cross-dehydrogenative coupling (CDC) in recent years. However, heating at temperature about 100 °C in the presence of peroxy compounds becomes a major drawback of this strategy.^[@cit4c]−[@cit4h]^ Recently, Antonchick reported that PhI(OCOCF~3~)~2~/TMSN~3~ can efficiently mediate the oxidative CDC of a wide range of N-heterocycles with diverse aldehydes at room temperature ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}B).^[@cit4h]^ Our group is interested in photoredox catalysis,^[@ref7]^ and we recently employed abundant and inexpensive aroyl chlorides for the first time as novel acyl radical precursors in visible-light photocatalysis.^[@cit7f],[@cit7g]^ This method featured with easy available substrates, mild reaction conditions, and convenient operation procedure. Moreover, inspired by the properties of tris(trimethylsilyl)silane (TTMSS)^[@ref8]^ and the work of MacMillan,^[@ref9]^ photoredox catalysis or heat can induce radical initiators to generate silyl radical intermediates, which are able to abstract halogen atoms from alkyl C~sp^3^~-halide bonds to form the strong Si-halogen bond. We expected that the sulfate radical anion, which is readily generated from single-electron transfer (SET) between the photocatalyst and persulfate, could also abstract a hydrogen atom from TTMSS to produce the silyl radical. We believe this novel approach could be utilized in Minisci alkylation. Specifically, we herein report two novel methods for Minisci aroylation and alkylation mediated by photoredox catalysis, where commercial available aroyl chlorides and bromoalkanes are used as radical precursors, respectively ([Scheme [1](#sch1){ref-type="scheme"}](#sch1){ref-type="scheme"}C). Simultaneously, reaction mechanisms were studied at full length to support our hypotheses.

![Minisci Aroylation and Alkylation of Heteroarenes](ao9b01674_0001){#sch1}

Results and Discussion {#sec2}
======================

Our studies of the Minisci aroylation were initiated with the reaction of isoquinoline **1a** and benzoyl chloride **2a** ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}). The reaction was irradiated for 48 h with blue light-emitting diode (LED) strips using Ir(ppy)~3~ as the photocatalyst ([Table [1](#tbl1){ref-type="other"}](#tbl1){ref-type="other"}, entry 4). Surprisingly, the desired product **3a** was obtained in 32% yield in MeCN. Screening of the photocatalysts showed that less reducing systems were not effective (entries 1--3). Moreover, it was found that the presence of an acid additive, which was essential in traditional Minisci reaction, decreased the reaction efficiency (entry 5), although the yield could be recovered by extending the reaction time to 72 h (entry 6). Furthermore, the excess amount of benzoyl chloride (up to 10 equiv) had a significant influence on the reaction outcome, delivering the desired product up to 88% yield (entries 7 and 8). It was confirmed that both the photocatalyst and light were required for the reaction by control experiments (entries 9 and 10).

###### Initial Studies of the Minisci Aroylation Reaction[a](#t1fn1){ref-type="table-fn"}

![](ao9b01674_0004){#GRAPHIC-d7e264-autogenerated}

  entry                                Catalyst                  **1a**/**2a**   time (h)   yield (%)[b](#t1fn2){ref-type="table-fn"}
  ------------------------------------ ------------------------- --------------- ---------- -------------------------------------------
  1                                    Ru(bpy)~3~Cl~2~           1:2             48         NR
  2                                    Ir(ppy)~2~(dtbbpy)PF~6~   1:2             48         NR
  3                                    eosin Y                   1:2             48         NR
  4                                    *fac*-Ir(ppy)~3~          1:2             48         32
  5[c](#t1fn3){ref-type="table-fn"}    *fac*-Ir(ppy)~3~          1:2             48         20
  6                                    *fac*-Ir(ppy)~3~          1:2             72         35
  7                                    *fac*-Ir(ppy)~3~          1:6             72         74
  8                                    *fac*-Ir(ppy)~3~          1:10            72         88
  9                                    None                      1:10            72         NR
  10[d](#t1fn4){ref-type="table-fn"}   *fac*-Ir(ppy)~3~          1:10            72         NR

Unless otherwise noted, reaction conditions are as follows: substrate **1a** (0.2 mmol), **2a** (2--10 equiv), photocatalyst (0.004 mmol), MeCN (anhydrous, 2 mL), 25 W blue LED strips, room temperature, and under the N~2~ atmosphere.

Isolated yield.

With additive of TFA (0.2 mmol).

In the dark.

With the reaction conditions optimized, we next performed a series of experiments to determine the scope of the substrates. As shown in [Table [2](#tbl2){ref-type="other"}](#tbl2){ref-type="other"}, a variety of heteroarenes were readily aroylated with a range of aroyl chlorides in moderate to excellent yields. First, the scope of aryl chlorides was investigated using isoquinoline as the heteroarene substrate. To our delight, electron-donating/withdrawing groups substituted in different sites of aroyl chlorides were well-tolerated. More specifically, monosubstituted benzoyl chlorides bearing halogen, trifluoromethyl, methyl, and *tert*-butyl groups provided the corresponding products in 42--78% yields under the standard conditions (**3b** to **3k**), and disubstituted benzoyl chlorides were also well tolerated, delivering the desired products in 57--80% yields (**3l** and **3m**). The scope of the reaction was further extended to 2-naphthoyl chloride (**3n**) and 2-thiophenecarbonyl chloride (**3o**).

###### Scope of Substrates toward Minisci Aroylation Reaction[a](#t2fn1){ref-type="table-fn"}
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![](ao9b01674_0006){#gr4}

Unless otherwise noted, reaction conditions are as follows: **1** (0.2 mmol), **2** (2.0 mmol), *fac*-Ir(ppy)~3~ (0.004 mmol), MeCN (anhydrous, 2 mL), 25 W blue LED strips, room temperature, under the N~2~ atmosphere, and 72 h. All yields are isolated yields.

Next, the scope of the heteroarenes was investigated using benzoyl chloride as the radical source. Monosubstituted quinolines served as suitable substrates, generating the corresponding acylated products as single regioisomers at the C1 position in good yields (**3p--3r**). The reaction using quinoxaline delivered mono- (**3s**) and diaroylated (**3s′**) products in 35 and 60% yields, respectively. Furthermore, C2-substituted quinoxalines could also be aroylated at the C3 position in good yields (**3t** and **3u**). Other heteroarenes, such as quinazoline (**3v**), acridine (**3w**), 4-cyano-pyridine (**3x**), benzothiazole (**3y**), and 2,3-diphenylpyrido\[3,4-*b*\]pyrazine (**3z**), were monoaroylated smoothly at the most electrophilic position.

Based on the previous works of our group^[@cit7f],[@cit7g]^ and mechanism studies, a possible mechanism for the visible light-mediated aroylation of heteroarenes was proposed as depicted in [Scheme [2](#sch2){ref-type="scheme"}](#sch2){ref-type="scheme"}. Under irradiation of blue LEDs, the photocatalyst *fac*-Ir^III^(ppy)~3~ was excited to form the strong reductant \**fac*-Ir^III^(ppy)~3~ (*E*~1/2~^IV/\*III^ = −1.73 V vs SCE),^[@ref10]^ which reduced benzoyl chloride (*E*~p/2~ = −1.35 V vs SCE)^[@ref11]^ via SET to deliver *fac*-Ir^IV^(ppy)~3~ and radical anion **IV**. After dechloridation, the key aroyl radical **V** was added to the heteroarene to provide **VI**. Upon deprotonation, oxidation of the *fac*-Ir^IV^(ppy)~3~ (*E*~1/2~^IV/III^ = +0.77 V vs SCE) through SET from **VII** furnished the desired product **VIII**.

![Proposed Mechanism for Minisci Aroylation Reaction](ao9b01674_0002){#sch2}

Having completed our studies of Minisci aroylation, we next turned our attention to Minisci alkylation as another part of this work. As mentioned in the introduction, we hypothesized that persulfate and TTMSS will facilitate the generation of alkyl radicals from bromoalkanes under photoredox conditions. Our study thus started with isoquinoline, bromocyclohexane, TTMSS, trifluoroacetic acid (TFA), and a series of photocatalysts and oxidants. To our delight, the desired alkylated product **6a** was obtained in 17% yield using Ir(ppy)~2~(dtbbpy)PF~6~ in combination with DTBP as the oxidant in dimethyl sulfoxide (DMSO) under the irradiation of 25 W blue LED strips. Finally, we promoted the yield to 90% by screening the kind and the loading of photocatalysts, oxidants, and solvents.^[@ref12]^

With the reaction conditions optimized, we next explored the scope of this photoinduced Minisci-type C--H alkylation by investigating the reactions between *N*-heteroarenes and various bromoalkanes. First, the scope of bromoalkanes was investigated. As summarized in [Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}, in addition to the model substrate, four- and five-membered cyclic systems were also tolerated, albeit with reduced yields (**6b** and **6c**). Both acyclic primary and secondary alkyl halides reacted efficiently with isoquinoline to generate the corresponding products (**6d** to **6k**) in moderate to good yields. Notably, unsaturated bromohydrocarbons containing a phenyl (**6l** to **6n**) or alkenyl (**6o** to **6q**) group were also shown to be competent substrates. Lastly, ethyl 5-bromopentanoate, bearing an ester group, was found to react with isoquinoline readily in a synthetically useful yield (**6r**, 56%).

###### Scope of Substrates toward Minisci Alkylation Reaction[a](#t3fn1){ref-type="table-fn"}
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Unless otherwise noted, reaction conditions are as follows: **4** (0.2 mmol), **5** (0.4 mmol), Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~ (0.002 mmol), TFA (0.4 mmol), K~2~S~2~O~8~ (0.4 mmol), TTMSS (0.4 mmol), DMSO (anhydrous, 1 mL), 25 W blue LED strips, room temperature, under the N~2~ atmosphere, and 12 h. All yields are isolated yields.

To further demonstrate the functional group tolerance and applicability of this method, we examined the scope of this reaction with different electron-deficient heteroarenes ([Table [3](#tbl3){ref-type="other"}](#tbl3){ref-type="other"}). Both quinolines and isoquinolines were well tolerated (**6s** to **6w**). Quinolines substituted at C4 and C2 positions gave C2 and C4 alkylated products, respectively (**6s** to **6u**). Other heterocycles such as quinoxalines (**6x** and **6y**), benzothiazole (**6z**), 2,3-diphenylpyrido\[3,4-*b*\]pyrazine (**6aa**), 6-chloroimidazo\[1,2-*b*\]pyridazine (**6ab**), and 4-cyanopyridine (**6ac**) were also proved to be suitable substrates for this Minisci-type alkylation protocol. For quinazoline, both mono- and double-alkylated products were obtained with the monoalkylation product as the major product (**6ad** and **6ad′**).

Mechanism studies were also carried out. According to the results of fluorescence quenching experiments, the excited photocatalyst **X** was quenched by isoquinoline instead of potassium persulfate. Moreover, giving the results of cyclic voltammetry (CV) experiments and literature reports, we supposed that isoquinoline and other heteroarenes might act as both substrates and electron transfer agents.^[@ref13]^ Taken together, these observations indicated an oxidative quenching pathway, wherein direct reduction of persulfate by heterocyclic compound intermediate **XIX** was a viable electron transfer pathway. Radical trapping experiments clearly showed a radical mechanistic pathway. Quantum yield measurements (Φ = 9.3) suggested that radical propagation was involved in the reaction.

Based on the literature and our studies, a plausible mechanism for the visible light-mediated alkylation of heteroarenes was proposed and illustrated in [Scheme [3](#sch3){ref-type="scheme"}](#sch3){ref-type="scheme"}. Photoexcitation of the Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~ photocatalyst with blue LEDs produced a long-lived excited state, \*Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~. The resulting \*Ir^III^ species **X**, as a reductant (*E*~1/2~^\*III/IV^ = −0.89 V vs SCE),^[@ref14]^ should be able to reduce electron transfer agent **XVIII** (*E*~p/2~^red^ = −1.08 V vs SCE) to afford the oxidized iridium species **XI** and radical intermediate **XIX**. The SET process between persulfate and **XIX** delivered sulfate anion radical **XII**. In addition, **XII** could also be formed by the thermolysis of persulfate.^[@ref16]^ The generated sulfate radical anion underwent a hydrogen-atom transfer process with TTMSS to afford silyl radical **XIII**, which abstracted a bromine atom from the bromoalkane to afford the key alkyl radical **XIV**. The alkyl radical **XIV** was then added to the electron-deficient heteroarene to provide **XV**. Upon deprotonation, reduction of **XVI** (*E*~1/2~^ox^ = −0.92 to −1.12 V vs SCE)^[@ref15]^ through a SET process with **XI** (*E*~1/2~^IV/III^ = +1.69 V vs SCE)^[@ref14]^ furnished the desired product. Alternatively, the persulfate anion could act as a chain carrier, which oxidized **XVI** to provide the alkylated heteroarene **XVII**.

![Proposed Mechanism for Minisci Alkylation Reaction](ao9b01674_0003){#sch3}

Conclusions {#sec3}
===========

In summary, we have developed photoredox-catalyzed Minisci alkylation and aroylation using bromoalkanes and aroyl chlorides as the radical precursors, respectively. These methods enabled the rapid synthesis of a series of Minisci-type adducts using commercially available starting materials under mild reaction conditions with easy operation. We expect that these new versions of the Minisci reaction will find more applications in organic synthesis.

Experimental Section {#sec4}
====================

General Information {#sec4.1}
-------------------

All glassware was thoroughly oven-dried. Chemicals and solvents were either purchased from commercial suppliers or purified by standard techniques. Analytical high-performance thin-layer chromatography was performed on silica gel glass plates with the F-254 indicator, and compounds were visualized by exposure to ultraviolet light and/or staining with phosphomolybdic acid followed by heating on a hot plate. Flash chromatography was carried out using silica gel (200--300 mesh). ^1^H NMR and ^13^C NMR spectra were recorded on a Bruker AM-400 spectrometer (400 MHz ^1^H, 100 MHz ^13^C) using CDCl~3~ as a solvent for deuterium locking with a temperature of 298 K. Chemical shifts are given in ppm with TMS as an internal reference. *J* values are given in Hertz. High-resolution mass spectrometry (HRMS) were performed on a Bruker Apex II mass instrument (ESI). All fluorescence spectra were surveyed on a PE-LS55 fluorescence spectrophotometer and equipped with a 1 cm quartz cell. All CV curves were measured on a CHI660E electrochemical workstation. During the study of quantum yield, the reaction was irradiated in a Parallel Light Reactor (WP-TEC-1020), and the yield was determined by gas chromatography--mass spectrometry (EI).

General Procedure for the Synthesis of Aroylated Heteroarenes {#sec4.2}
-------------------------------------------------------------

A mixture of *fac*-Ir(ppy)~3~ (2.6 mg, 0.004 mmol, 0.02 equiv), heteroarenes **1** (0.2 mmol, 1.0 equiv), aroyl chloride **2** (2.0 mmol, 10.0 equiv), and MeCN (2 mL) was degassed by three cycles of freeze--pump--thaw. The mixture was stirred under nitrogen atmosphere at room temperature while irradiated by blue LEDs for 72 h. After completion of the reaction, the solvent was removed in vacuo, and the residue was purified by flash chromatography (petroleum ether/ethyl acetate) on silica gel to afford the aroylated products **3**.

General Procedure for the Synthesis of Alkylated Heteroarenes {#sec4.3}
-------------------------------------------------------------

A mixture of Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~ (1 mol %), heteroarenes **4** (0.2 mmol, 1.0 equiv), TFA (30 μL, 0.4 mmol, 2.0 equiv), bromoalkane **5** (0.4 mmol, 2.0 equiv), K~2~S~2~O~8~ (108 mg, 0.4 mmol, 2.0 equiv), TTMSS (120 μL, 0.4 mmol, 2.0 equiv), and DMSO (1 mL) was degassed by three cycles of freeze--pump--thaw. The mixture was stirred under the nitrogen atmosphere at room temperature while irradiated by blue LEDs for 12 h. After completion of the reaction, the reaction mixture was neutralized with NaHCO~3~ and diluted with 25 mL ethyl acetate; the organic layer was washed with brine (30 mL × 3), dried over Na~2~SO~4~, and then concentrated in vacuo. Purification of the crude product by flash chromatography (petroleum ether/ethyl acetate) on silica gel was carried out to afford the alkylated product **6**.

Trapping Experiments with TEMPO {#sec4.4}
-------------------------------

The trapping experiment for Minisci aroylation was conducted as follows: isoquinoline **1a** (0.2 mmol), benzoyl chloride **2a** (2.0 mmol), TEMPO (2.0 mmol.), Ir(ppy)~3~ (0.004 mmol), MeCN (anhydrous, 2 mL), 25 W blue LED strips, room temperature, under the N~2~ atmosphere, and 72 h. The TEMPO-trapped compound **7** was detected by HRMS techniques. HRMS (ESI): for C~16~H~23~NO~2~ \[M + H\]^+^ calcd, 262.1807; found, 262.1803.

Trapping experiments for Minisci alkylation were conducted as follows: isoquinoline **1a** (0.2 mmol), bromocyclohexane **5a** (0.4 mmol), TEMPO (0.4 mmol), Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~ (0.002 mmol), TFA (0.4 mmol), oxidant (0.4 mmol), TTMSS (0.4 mmol), DMSO (anhydrous, 1 mL), room temperature, under the N~2~ atmosphere, and 12 h. One was irradiated with blue LEDs, and the other one reacted in the dark. The TEMPO-trapped compound **8** was detected in both reactions by HRMS techniques. HRMS (ESI): for C~16~H~23~NO~2~ \[M + H\]^+^ calcd, 240.2327; found, 240.2324.

Fluorescence Quenching Experiments {#sec4.5}
----------------------------------

As for Minisci aroylation, Stern--Volmer fluorescence quenching experiments were run with freshly prepared solutions of 0.1 mM Ir(ppy)~3~ and substrates with the concentration gradient from 0.2 to 1.0 mM in degassed dry MeCN at room temperature. The solutions were irradiated at 376 nm, and the fluorescence was measured from 400 to 700 nm.

As for Minisci alkylation, Stern--Volmer fluorescence quenching experiments were run with freshly prepared solutions of 0.1 mM Ir\[dF(CF~3~)ppy\]~2~(dtbbpy)PF~6~ and substrates/additives with the concentration gradient from 0.2 to 1.0 mM in degassed dry DMSO at room temperature. The solutions were irradiated at 336 nm, and the fluorescence was measured from 300 to 700 nm.

CV Experiments {#sec4.6}
--------------

Electrolyte solution was prepared by dissolving substrates (0.2 mmol, 0.01 M) and tetrabutylammonium tetrafluoroborate (658 mg, 2.0 mmol, 0.1 M) in MeCN (20 mL). Measurements were performed in a three-compartment electrochemical cell, in which the glassy carbon electrode was used as a working electrode, AgNO~3~/Ag electrode as the reference electrode, and Pt wire as the counter electrode. Scan rates were 100 mV/s, and the CV curves were thus obtained.

### Isoquinolin-1-yl(phenyl)methanone (**3a**) {#sec4.6.1}

It was obtained as a yellow solid; 41.0 mg, 88% yield; *R*~f~ = 0.27 (PE/EA = 10:1); mp 62--64 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.22 (d, *J* = 8.5 Hz, 1H), 7.99--7.93 (m, 2H), 7.91 (d, *J* = 8.3 Hz, 1H), 7.80 (d, *J* = 5.6 Hz, 1H), 7.77--7.70 (m, 1H), 7.64--7.57 (m, 2H), 7.47 (t, *J* = 7.7 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.7, 156.4, 141.1, 136.7, 136.6, 133.6, 130.7, 130.6, 128.4, 128.3, 127.0, 126.4, 126.1, 122.5; HRMS (ESI): for C~16~H~11~NO \[M + H\]^+^ calcd, 234.0919; found, 234.0912.

### (4-Fluorophenyl)(isoquinolin-1-yl)methanone (**3b**) {#sec4.6.2}

It was obtained as a white solid; 30.6 mg, 61% yield; *R*~f~ = 0.25 (PE/EA = 10:1); mp 64--66 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.24 (dd, *J* = 8.5, 0.8 Hz, 1H), 8.04--7.98 (m, 2H), 7.93 (d, *J* = 8.3 Hz, 1H), 7.82 (d, *J* = 5.6 Hz, 1H), 7.78--7.73 (m, 1H), 7.66--7.63 (m, 1H), 7.19--7.11 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.0, 167.3, 164.8, 155.9, 141.0, 136.7, 133.5, 133.4, 132.9, 130.7, 128.4, 127.1, 126.3, 126.0, 122.7, 115.7, 115.5; HRMS (ESI): for C~16~H~10~FNO \[M + H\]^+^ calcd, 252.0825; found, 252.0818.

### (4-Chlorophenyl)(isoquinolin-1-yl)methanone (**3c**) {#sec4.6.3}

It was obtained as colorless oil; 39.6 mg, 74% yield; *R*~f~ = 0.32 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.26 (dd, *J* = 8.6, 0.8 Hz, 1H), 7.96--7.89 (m, 3H), 7.83 (d, *J* = 5.6 Hz, 1H), 7.79--7.73 (m, 1H), 7.67--7.62 (m, 1H), 7.48--7.43 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.3, 155.5, 141.0, 140.1, 136.7, 134.9, 132.1, 130.7, 128.7, 128.5, 127.1, 126.4, 126.0, 122.9; HRMS (ESI): for C~16~H~10~ClNO \[M + H\]^+^ calcd, 268.0529; found, 268.0528.

### (4-Bromophenyl)(isoquinolin-1-yl)methanone (**3d**) {#sec4.6.4}

It was obtained as colorless oil; 26.2 mg, 42% yield; *R*~f~ = 0.31 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.26 (dd, *J* = 8.4, 0.8 Hz, 1H), 7.93 (d, *J* = 8.3 Hz, 1H), 7.85 (t, *J* = 1.9 Hz, 1H), 7.83 (t, *J* = 2.5 Hz, 2H), 7.79--7.73 (m, 1H), 7.67--7.64 (m, 1H), 7.64--7.60 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.5, 155.5, 141.0, 136.7, 135.4, 132.2, 131.7, 130.8, 128.9, 128.5, 127.1, 126.4, 126.0, 122.9; HRMS (ESI): for C~16~H~10~BrNO \[M + H\]^+^ calcd, 312.0024; found, 312.0028.

### Isoquinolin-1-yl(4-(trifluoromethyl)phenyl)methanone (**3e**) {#sec4.6.5}

It was obtained as a white solid; 31.4 mg, 52% yield; *R*~f~ = 0.34 (PE/EA = 10:1); mp 78--80 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.61 (d, *J* = 5.6 Hz, 1H), 8.36 (dd, *J* = 8.4, 0.8 Hz 1H), 8.08 (d, *J* = 8.1 Hz, 2H), 7.96 (d, *J* = 8.3 Hz, 1H), 7.86 (d, *J* = 5.3 Hz, 1H), 7.82--7.72 (m, 3H), 7.71--7.65 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.4, 154.8, 141.0, 139.7, 136.8, 134.6, 134.3, 131.0, 130.8, 128.7, 127.2, 126.6, 125.9, 125.4, 125.4, 125.3, 125.3, 124.9, 123.4, 122.2; HRMS (ESI): for C~17~H~10~F~3~NO \[M + H\]^+^ calcd, 302.0793; found, 302.0788.

### Isoquinolin-1-yl(*p*-tolyl)methanone (**3f**) {#sec4.6.6}

It was obtained as colorless oil; 36.1 mg, 73% yield; *R*~f~ = 0.25 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.59 (d, *J* = 5.7 Hz, 1H), 8.19 (dd, *J* = 8.8, 0.8, 1H), 7.91 (d, *J* = 8.3 Hz, 1H), 7.85 (d, *J* = 8.2 Hz, 2H), 7.79 (d, *J* = 5.6 Hz, 1H), 7.75--7.70 (m, 1H), 7.63--7.57 (m, 1H), 7.27 (d, *J* = 7.8 Hz, 2H), 2.42 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.4, 156.7, 144.6, 141.1, 136.6, 130.8, 130.6, 129.1, 128.1, 127.0, 126.3, 126.1, 122.3, 21.7; HRMS (ESI): for C~17~H~13~NO \[M + H\]^+^ calcd, 248.1075; found, 248.1069.

### (4-(*tert*-Butyl)phenyl)(isoquinolin-1-yl)methanone (**3g**) {#sec4.6.7}

It was obtained as colorless oil; 34.1 mg, 59% yield; *R*~f~ = 0.33 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.22 (d, *J* = 8.5 Hz, 1H), 7.95--7.86 (m, 3H), 7.80 (d, *J* = 5.6 Hz, 1H), 7.77--7.70 (m, 1H), 7.63--7.58 (m, 1H), 7.53--7.46 (m, 2H), 1.34 (s, 9H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.3, 157.5, 156.7, 141.1, 136.6, 133.9, 130.7, 130.6, 128.1, 127.0, 126.3, 126.2, 125.4, 122.3, 35.1, 31.0; HRMS (ESI): for C~20~H~19~NO \[M + H\]^+^ calcd, 290.1545; found, 290.1538.

### Isoquinolin-1-yl(*o*-tolyl)methanone (**3h**) {#sec4.6.8}

It was obtained as colorless oil; 38.5 mg, 78% yield; *R*~f~ = 0.27 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.20 (d, *J* = 8.5 Hz, 1H), 7.92 (d, *J* = 8.3 Hz, 1H), 7.80 (d, *J* = 5.6 Hz, 1H), 7.79--7.69 (m, 3H), 7.62 (t, *J* = 7.7 Hz, 1H), 7.42 (d, *J* = 7.6 Hz, 1H), 7.35 (t, *J* = 7.6 Hz, 1H), 2.39 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 195.0, 156.6, 141.1, 138.2, 136.6, 134.5, 131.0, 130.6, 128.3, 128.2, 128.0, 127.0, 126.3, 126.1, 122.4, 21.3; HRMS (ESI): for C~17~H~13~NO \[M + H\]^+^ calcd, 248.1075; found, 248.1069.

### (2-Chlorophenyl)(isoquinolin-1-yl)methanone (**3i**) {#sec4.6.9}

It was obtained as colorless oil; 39.7 mg, 74% yield; *R*~f~ = 0.25 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.74 (d, *J* = 8.3 Hz, 1H), 8.53 (d, *J* = 5.6 Hz, 1H), 7.91 (d, *J* = 7.5 Hz, 1H), 7.80 (d, *J* = 5.5 Hz, 1H), 7.79--7.68 (m, 3H), 7.48--7.37 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 196.0, 154.4, 141.2, 139.0, 136.9, 132.4, 132.2, 130.9, 130.5, 130.0, 128.9, 127.0, 126.8, 126.3, 126.3, 123.8; HRMS (ESI): for C~16~H~10~ClNO \[M + H\]^+^ calcd, 268.0529; found, 268.0525.

### Isoquinolin-1-yl(*m*-tolyl)methanone (**3j**) {#sec4.6.10}

It was obtained as colorless oil; 30.2 mg, 61% yield; *R*~f~ = 0.27 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.6 Hz, 1H), 8.19 (d, *J* = 8.5 Hz, 1H), 7.91 (d, *J* = 8.3 Hz, 1H), 7.80 (d, *J* = 5.6 Hz, 1H), 7.78--7.70 (m, 3H), 7.63--7.58 (m, 1H), 7.42 (d, *J* = 7.6 Hz, 1H), 7.35 (t, *J* = 7.6 Hz, 1H), 2.38 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.9, 156.6, 141.1, 138.2, 136.6, 136.6, 134.4, 130.9, 130.6, 128.3, 128.2, 128.0, 127.0, 126.3, 126.1, 122.4, 21.2; HRMS (ESI): for C~17~H~13~NO \[M + H\]^+^ calcd, 248.1075; found, 248.1071.

### (3-Chlorophenyl)(isoquinolin-1-yl)methanone (**3k**) {#sec4.6.11}

It was obtained as a white solid; 39.1 mg, 73% yield; *R*~f~ = 0.29 (PE/EA = 10:1); mp 80--82 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.61 (d, *J* = 5.6 Hz, 1H), 8.27 (dq, *J* = 8.5, 0.9 Hz, 1H), 7.97--7.91 (m, 2H), 7.86--7.81 (m, 2H), 7.79--7.74 (m, 1H), 7.68--7.63 (m, 1H), 7.60--7.56 (m, 1H), 7.42 (t, *J* = 7.9 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.2, 155.3, 141.1, 138.3, 136.8, 130.8, 130.6, 129.7, 128.9, 128.5, 127.1, 126.5, 126.0, 123.0; HRMS (ESI): for C~16~H~10~ClNO \[M + H\]^+^ calcd, 268.0529; found, 268.0524.

### (3,5-Dimethylphenyl)(isoquinolin-1-yl)methanone (**3l**) {#sec4.6.12}

It was obtained as colorless oil; 41.7 mg, 80% yield; *R*~f~ = 0.27 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.60 (d, *J* = 5.7 Hz, 1H), 8.23--8.12 (m, 1H), 7.92 (d, *J* = 8.3 Hz, 1H), 7.80 (d, *J* = 5.6 Hz, 1H), 7.76--7.71 (m, 1H), 7.63--7.58 (m, 1H), 7.54 (s, 2H), 7.24 (s, 1H), 2.33 (s, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 195.2, 156.9, 141.1, 138.1, 136.6, 136.6, 135.4, 130.6, 128.3, 128.1, 127.0, 126.2, 126.1, 122.3, 21.1; HRMS (ESI): for C~18~H~15~NO \[M + H\]^+^ calcd, 262.1232; found, 262.1226.

### (3,4-Dichlorophenyl)(isoquinolin-1-yl)methanone (**3m**) {#sec4.6.13}

It was obtained as a white solid; 34.4 mg, 57% yield; *R*~f~ = 0.36 (PE/EA = 10:1); mp 128--130 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.61 (d, *J* = 5.6 Hz, 1H), 8.30 (dd, *J* = 8.4, 0.8 Hz, 1H), 8.08 (d, *J* = 2.0 Hz, 1H), 7.95 (d, *J* = 8.3 Hz, 1H), 7.86 (d, *J* = 5.5 Hz, 1H), 7.82 (dd, *J* = 8.4, 2.0 Hz, 1H), 7.80--7.75 (m, 1H), 7.67 (ddd, *J* = 8.2, 6.9, 1.2 Hz, 1H), 7.56 (d, *J* = 8.4 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 192.1, 154.6, 141.0, 138.0, 136.8, 136.3, 133.0, 132.6, 130.8, 130.4, 129.7, 128.7, 127.2, 126.5, 125.9, 123.3; HRMS (ESI): for C~16~H~9~Cl~2~NO \[M + H\]^+^ calcd, 302.0139; found, 302.0135.

### Isoquinolin-1-yl(naphthalen-2-yl)methanone (**3n**) {#sec4.6.14}

It was obtained as a white solid; 11.9 mg, 21% yield; *R*~f~ = 0.21 (PE/EA = 10:1); mp 98--100 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.65 (d, *J* = 5.6 Hz, 1H), 8.34 (s, 1H), 8.25 (dd, *J* = 8.4, 0.8 Hz, 1H), 8.15 (dd, *J* = 8.6, 1.7 Hz, 1H), 7.96 (dd, *J* = 8.4, 3.6 Hz, 2H), 7.93--7.82 (m, 3H), 7.81--7.73 (m, 1H), 7.68--7.56 (m, 2H), 7.56--7.46 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.7, 156.7, 141.2, 136.7, 135.9, 133.9, 133.7, 132.3, 130.7, 129.8, 128.8, 128.4, 128.3, 127.7, 126.6, 126.4, 126.2, 125.2, 122.5; HRMS (ESI): for C~20~H~13~NO \[M + H\]^+^ calcd, 284.1075; found, 284.1069.

### Isoquinolin-1-yl(thiophen-2-yl)methanone (**3o**) {#sec4.6.15}

It was obtained as a yellow solid; 20.5 mg, 43% yield; *R*~f~ = 0.26 (PE/EA = 10:1); mp 72--74 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.66 (d, *J* = 5.6 Hz, 1H), 8.58 (d, *J* = 8.5 Hz, 1H), 7.97--7.91 (m, 2H), 7.86 (d, *J* = 5.6 Hz, 1H), 7.81--7.78 (m, 1H), 7.78--7.74 (m, 1H), 7.71--7.66 (m, 1H), 7.21--7.16 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 186.0, 154.6, 142.5, 140.8, 136.9, 136.5, 135.9, 130.6, 128.6, 128.0, 127.0, 126.4, 126.2, 123.5; HRMS (ESI): for C~14~H~9~NOS \[M + H\]^+^ calcd, 240.0483; found, 240.0479.

### (5-Bromoisoquinolin-1-yl)(phenyl)methanone (**3p**) {#sec4.6.16}

It was obtained as a white solid; 51.0 mg, 82% yield; *R*~f~ = 0.42 (PE/EA = 10:1); mp 94--96 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.70 (d, *J* = 5.9 Hz, 1H), 8.19--8.15 (m, 2H), 8.01 (dd, *J* = 7.5, 0.8 Hz, 1H), 7.95--7.90 (m, 2H), 7.63--7.58 (m, 1H), 7.50--7.41 (m, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.1, 156.8, 142.5, 136.3, 135.7, 134.3, 133.8, 130.6, 128.5, 128.4, 127.3, 125.8, 121.9, 121.3; HRMS (ESI): for C~16~H~10~BrNO \[M + H\]^+^ calcd, 312.0024; found, 312.0019.

### (4-Bromoisoquinolin-1-yl)(phenyl)methanone (**3q**) {#sec4.6.17}

It was obtained as a white solid; 50.0 mg, 80% yield; *R*~f~ = 0.27 (PE/EA = 10:1); mp 96--98 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.80 (s, 1H), 8.27 (d, *J* = 8.5 Hz, 1H), 8.22 (d, *J* = 8.5 Hz, 1H), 7.94 (dd, *J* = 8.2, 1.1 Hz, 2H), 7.88--7.83 (m, 1H), 7.70--7.66 m, 1H), 7.65--7.58 (m, 1H), 7.48 (t, *J* = 7.7 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.8, 155.6, 142.8, 136.2, 133.8, 131.9, 130.6, 129.1, 128.4, 127.4, 126.5, 126.3, 121.7; HRMS (ESI): for C~16~H~10~BrNO \[M + H\]^+^ calcd, 312.0024; found, 312.0022.

### (6-Methylisoquinolin-1-yl)(phenyl)methanone (**3r**) {#sec4.6.18}

It was obtained as colorless oil; 31.6 mg, 64% yield; *R*~f~ = 0.22 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.55 (d, *J* = 5.6 Hz, 1H), 8.11 (d, *J* = 8.7 Hz, 1H), 7.98--7.92 (m, 2H), 7.72 (d, *J* = 5.6 Hz, 1H), 7.69 (s, 1H), 7.63--7.57 (m, 1H), 7.51--7.42 (m, 3H), 2.56 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.8, 156.0, 141.2, 137.0, 133.5, 130.7, 130.6, 128.4, 125.8, 124.8, 122.0, 21.9; HRMS (ESI): for C~17~H~13~NO \[M + H\]^+^ calcd, 248.1075: found, 248.1071.

### Phenyl(quinoxalin-2-yl)methanone (**3s**) {#sec4.6.19}

It was obtained as a white solid; 16.3 mg, 35% yield; *R*~f~ = 0.28 (PE/EA = 10:1); mp 62--64 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 9.50 (s, 1H), 8.25 (d, *J* = 7.6 Hz, 2H), 8.21 (d, *J* = 8.4 Hz, 2H), 7.96--7.83 (m, 2H), 7.67 (t, *J* = 7.4 Hz, 1H), 7.55 (t, *J* = 7.7 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 192.3, 148.6, 145.3, 143.1, 140.4, 135.5, 133.6, 132.0, 131.2, 130.4, 128.3; HRMS (ESI): for C~15~H~10~N~2~O \[M + H\]^+^ calcd, 235.0871; found, 235.0868.

### Quinoxaline-2,3-diylbis(phenylmethanone) (**3s′**) {#sec4.6.20}

It was obtained as a white solid; 40.5 mg, 60% yield; *R*~f~ = 0.23 (PE/EA = 10:1); mp 154--156 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.22 (dt, *J* = 6.5, 3.3 Hz, 2H), 8.14--8.09 (m, 4H), 7.93 (dt, *J* = 6.4, 3.2 Hz, 2H), 7.68--7.61 (m, 2H), 7.52 (t, *J* = 7.7 Hz, 4H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 192.5, 151.9, 140.1, 135.0, 133.9, 132.1, 130.9, 129.8, 128.5; HRMS (ESI): for C~22~H~14~N~2~O~2~ \[M + H\]^+^ calcd, 339.1134; found, 339.1133.

### (3-Methylquinoxalin-2-yl)(phenyl)methanone (**3t**) {#sec4.6.21}

It was obtained as a yellow solid; 40.2 mg, 81% yield; *R*~f~ = 0.27 (PE/EA = 10:1); mp 66--68 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.10 (d, *J* = 8.5 Hz, 2H), 8.00--7.94 (m, 2H), 7.87--7.81 (m, 1H), 7.80--7.73 (m, 1H), 7.66 (t, *J* = 7.4 Hz, 1H), 7.51 (t, *J* = 7.8 Hz, 2H), 2.81 (s, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 194.0, 152.2, 150.7, 142.0, 139.3, 135.4, 134.1, 131.2, 130.6, 129.7, 129.4, 128.6, 128.5, 22.7; HRMS (ESI): for C~16~H~12~N~2~O \[M + H\]^+^ calcd, 249.1028; found, 249.1024.

### (3-Chloroquinoxalin-2-yl)(phenyl)methanone (**3u**) {#sec4.6.22}

It was obtained as a white solid; 46.6 mg, 87% yield; *R*~f~ = 0.36 (PE/EA = 10:1); mp 122--124 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.19--8.09 (m, 2H), 7.96--7.83 (m, 4H), 7.68 (tt, *J* = 7.2, 1.3 Hz, 1H), 7.56--7.49 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 191.2, 150.2, 143.9, 142.0, 139.6, 134.6, 134.6, 132.2, 130.9, 130.4, 129.4, 128.8, 128.4; HRMS (ESI): for C~15~H~9~ClN~2~O \[M + H\]^+^ calcd, 269.0482; found, 269.0483.

### Phenyl(quinazolin-4-yl)methanone (**3v**) {#sec4.6.23}

It was obtained as colorless oil; 25.2 mg, 54% yield; *R*~f~ = 0.32 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 9.44 (s, 1H), 8.17 (d, *J* = 8.5 Hz, 1H), 8.08 (d, *J* = 8.4 Hz, 1H), 8.04--7.93 (m, 3H), 7.72--7.63 (m, 2H), 7.51 (t, *J* = 7.8 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 192.9, 164.0, 153.8, 151.2, 135.2, 134.6, 134.4, 130.6, 129.0, 128.7, 125.8, 122.0; HRMS (ESI): for C~15~H~10~N~2~O \[M + H\]^+^ calcd, 235.0871; found, 235.0866.

### Acridin-9-yl(phenyl)methanone (**3w**) {#sec4.6.24}

It was obtained as a yellow solid; 28.3 mg, 50% yield; *R*~f~ = 0.34 (PE/EA = 4:1); mp 140--142 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.31 (d, *J* = 8.8 Hz, 2H), 7.85--7.76 (m, 4H), 7.73 (d, *J* = 8.6 Hz, 2H), 7.62 (t, *J* = 7.4 Hz, 1H), 7.52--7.41 (m, 4H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 197.6, 148.6, 143.5, 137.1, 134.6, 130.3, 129.9, 129.0, 126.7, 125.3; HRMS (ESI): for C~20~H~13~NO \[M + H\]^+^ calcd, 284.1075; found, 284.1072.

### 2-Benzoylisonicotinonitrile (**3x**) {#sec4.6.25}

It was obtained as colorless oil; 9.1 mg, 22% yield; *R*~f~ = 0.42 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.91 (d, *J* = 4.8 Hz, 1H), 8.28 (s, 1H), 8.08 (d, *J* = 7.3 Hz, 2H), 7.72 (d, *J* = 4.9 Hz, 1H), 7.64 (t, *J* = 7.4 Hz, 1H), 7.52 (t, *J* = 7.7 Hz, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 191.5, 156.1, 149.4, 135.1, 133.5, 131.0, 128.3, 127.2, 126.3, 121.9, 115.8; HRMS (ESI): for C~13~H~8~N~2~O \[M + H\]^+^ calcd, 209.0715; found, 209.0709.

### Benzo\[*d*\]thiazol-2-yl(phenyl)methanone (**3y**) {#sec4.6.26}

It was obtained as a white solid; 33.9 mg, 71% yield; *R*~f~ = 0.60 (PE/EA = 10:1); mp 88--90 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.56 (d, *J* = 7.3 Hz, 2H), 8.24 (d, *J* = 8.2 Hz, 1H), 8.02 (d, *J* = 7.6 Hz, 1H), 7.67 (t, *J* = 7.4 Hz, 1H), 7.62--7.51 (m, 4H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 185.3, 167.1, 153.8, 137.0, 134.9, 133.8, 131.2, 128.4, 127.5, 126.8, 125.7, 122.1; HRMS (ESI): for C~14~H~9~NOS \[M + H\]^+^ calcd, 240.0483; found, 240.0482.

### (2,3-Diphenylpyrido\[3,4-*b*\]pyrazin-5-yl)(phenyl)methanone (**3z**) {#sec4.6.27}

It was obtained as a white solid; 42.7 mg, 55% yield; *R*~f~ = 0.57 (PE/EA = 2:1); mp 142--144 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.87 (d, *J* = 5.7 Hz, 1H), 8.11 (d, *J* = 5.7 Hz, 1H), 7.94 (d, *J* = 7.3 Hz, 2H), 7.61 (t, *J* = 7.4 Hz, 1H), 7.58--7.53 (m, 2H), 7.48 (t, *J* = 7.7 Hz, 2H), 7.44--7.34 (m, 5H), 7.32 (t, *J* = 7.4 Hz, 1H), 7.25 (d, *J* = 3.4 Hz, 1H), 7.22 (d, *J* = 7.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 193.9, 159.3, 158.1, 155.0, 146.0, 143.6, 138.2, 137.6, 136.4, 134.8, 133.7, 130.3, 130.0, 129.8, 129.7, 129.5, 128.4, 128.4, 128.1, 122.7; HRMS (ESI): for C~26~H~17~N~3~O \[M + H\]^+^ calcd, 388.1450; found, 388.1444.

### 1-Cyclohexylisoquinoline (**6a**) {#sec4.6.28}

It was obtained as colorless oil; 38.0 mg, 90% yield; *R*~f~ = 0.38 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.48 (d, *J* = 5.7 Hz, 1H), 8.22 (d, *J* = 8.4 Hz, 1H), 7.80 (d, *J* = 8.0 Hz, 1H), 7.68--7.61 (m, 1H), 7.60--7.55 (m, 1H), 7.47 (d, *J* = 5.7 Hz, 1H), 3.56 (tt, *J* = 11.7, 3.2 Hz, 1H), 2.03--1.89 (m, 4H), 1.89--1.75 (m, 3H), 1.59--1.48 (m, 2H), 1.40 (tt, *J* = 12.7, 3.3 Hz, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 165.6, 141.8, 136.3, 129.4, 127.5, 126.7, 126.2, 124.6, 118.8, 41.4, 32.5, 26.8, 26.2; HRMS (ESI): for C~15~H~17~N \[M + H\]^+^ calcd, 212.1439; found, 212.1432.

### 1-Cyclopentylisoquinoline (**6b**) {#sec4.6.29}

It was obtained as colorless oil; 29.1 mg, 74% yield; *R*~f~ = 0.49 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.46 (d, *J* = 5.7 Hz, 1H), 8.24 (d, *J* = 8.4 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.68--7.61 (m, 1H), 7.60--7.56 (m, 1H), 7.48 (d, *J* = 5.7 Hz, 1H), 4.02 (p, *J* = 8.3 Hz, 1H), 2.22--2.02 (m, 4H), 1.97--1.85 (m, 2H), 1.83--1.70 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 164.6, 141.6, 136.2, 129.5, 127.3, 127.1, 126.7, 125.2, 118.9, 42.9, 26.0; HRMS (ESI): for C~14~H~15~N \[M + H\]^+^ calcd, 198.1282; found, 198.1274.

### 1-Cyclobutylisoquinoline (**6c**) {#sec4.6.30}

It was obtained as colorless oil; 21.2 mg, 58% yield; *R*~f~ = 0.40 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.49 (d, *J* = 5.7 Hz, 1H), 8.06 (d, *J* = 8.4 Hz, 1H), 7.80 (d, *J* = 8.2 Hz, 1H), 7.68--7.61 (m, 1H), 7.58--7.53 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 4.37 (p, *J* = 8.7 Hz, 1H), 2.63 (pd, *J* = 9.2, 2.4 Hz, 2H), 2.55--2.45 (m, 2H), 2.25--2.12 (m, 1H), 2.04--1.90 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 163.4, 141.7, 136.0, 129.6, 127.2, 126.7, 126.3, 125.1, 118.9, 39.3, 27.6, 18.5; HRMS (ESI): for C~13~H~13~N \[M + H\]^+^ calcd, 184.1126; found, 184.1118.

### 1-Butylisoquinoline (**6d**) {#sec4.6.31}

It was obtained as colorless oil; 21.4 mg, 58% yield; *R*~f~ = 0.24 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.16 (d, *J* = 8.3 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.65 (t, *J* = 7.4 Hz, 1H), 7.58 (t, *J* = 7.3 Hz, 1H), 7.49 (d, *J* = 5.6 Hz, 1H), 3.34--3.25 (m, 2H), 1.85 (p, *J* = 7.7 Hz, 2H), 1.50 (h, *J* = 7.4 Hz, 2H), 0.99 (t, *J* = 7.3 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 162.4, 141.8, 136.2, 129.6, 127.3, 126.9, 126.8, 125.3, 119.0, 35.2, 31.9, 22.9, 13.9; HRMS (ESI): for C~13~H~15~N \[M + H\]^+^ calcd, 186.1282; found, 186.1275.

### 1-Pentylisoquinoline (**6e**) {#sec4.6.32}

It was obtained as colorless oil; 25.9 mg, 65% yield; *R*~f~ = 0.49 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.15 (d, *J* = 8.4 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.65 (t, *J* = 7.1 Hz, 1H), 7.62--7.55 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 3.32--3.25 (m, 2H), 1.91--1.81 (m, 2H), 1.51--1.33 (m, 4H), 0.91 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 162.4, 141.8, 136.2, 129.7, 127.3, 126.8, 119.0, 35.4, 32.0, 29.4, 22.5, 14.0; HRMS (ESI): for C~14~H~17~N \[M + H\]^+^ calcd, 200.1439; found, 200.1432.

### 1-Hexylisoquinoline (**6f**) {#sec4.6.33}

It was obtained as colorless oil; 27.3 mg, 64% yield; *R*~f~ = 0.22 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.16 (d, *J* = 8.5 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.69--7.62 (m, 1H), 7.60--7.56 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 3.32--3.25 (m, 2H), 1.90--1.81 (m, 2H), 1.48 (p, *J* = 7.3 Hz, 2H), 1.34 (dqt, *J* = 12.5, 7.8, 3.6 Hz, 4H), 0.89 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 162.4, 141.8, 136.2, 129.6, 127.3, 125.3, 119.0, 35.5, 31.7, 29.7, 29.5, 22.5, 14.0; HRMS (ESI): for C~15~H~19~N \[M + H\]^+^ calcd, 214.1595; found, 214.1588.

### 1-Decylisoquinoline (**6g**) {#sec4.6.34}

It was obtained as colorless oil; 35.0 mg, 65% yield; *R*~f~ = 0.30 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.15 (d, *J* = 8.4 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.69--7.61 (m, 1H), 7.61--7.54 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 3.32--3.25 (m, 2H), 1.86 (p, *J* = 7.7 Hz, 2H), 1.47 (p, *J* = 6.9 Hz, 2H), 1.42--1.18 (m, 12H), 0.87 (t, *J* = 6.8 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 162.4, 141.8, 136.2, 129.6, 127.3, 126.8, 125.3, 35.5, 31.8, 29.9, 29.8, 29.5, 29.5, 29.5, 29.3, 22.6, 14.0; HRMS (ESI): for C~19~H~27~N \[M + H\]^+^ calcd, 270.2221; found, 270.2217.

### 1-Isobutylisoquinoline (**6h**) {#sec4.6.35}

It was obtained as colorless oil; 19.2 mg, 52% yield; *R*~f~ = 0.41 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.45 (d, *J* = 5.7 Hz, 1H), 8.16 (d, *J* = 8.5 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.67--7.63 (m, 1H), 7.60--7.55 (m, 1H), 7.50 (d, *J* = 5.7 Hz, 1H), 3.17 (d, *J* = 7.3 Hz, 2H), 2.37--2.22 (m, 1H), 1.00 (d, *J* = 6.6 Hz, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 161.6, 141.7, 136.2, 129.6, 127.3, 126.7, 125.5, 119.0, 44.1, 29.5, 22.8; HRMS (ESI): for C~13~H~15~N \[M + H\]^+^ calcd, 186.1282; found, 186.1274.

### 1-Isopropylisoquinoline (**6i**) {#sec4.6.36}

It was obtained as colorless oil; 24.6 mg, 72% yield; *R*~f~ = 0.43 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.49 (d, *J* = 5.7 Hz, 1H), 8.23 (d, *J* = 8.4 Hz, 1H), 7.81 (d, *J* = 8.0 Hz, 1H), 7.69--7.62 (m, 1H), 7.61--7.56 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 3.96 (hept, *J* = 6.9 Hz, 1H), 1.45 (d, *J* = 6.8 Hz, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 166.2, 141.7, 136.3, 129.5, 127.5, 126.8, 126.1, 124.7, 118.9, 30.9, 22.1; HRMS (ESI): for C~12~H~13~N \[M + H\]^+^ calcd, 172.1126; found, 172.1118.

### 1-(*sec*-Butyl)isoquinoline (**6j**) {#sec4.6.37}

It was obtained as colorless oil; 20.0 mg, 54% yield; *R*~f~ = 0.43 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.50 (d, *J* = 5.7 Hz, 1H), 8.23 (d, *J* = 8.5 Hz, 1H), 7.81 (d, *J* = 8.0 Hz, 1H), 7.69--7.63 (m, 1H), 7.61--7.56 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 3.72 (h, *J* = 6.9 Hz, 1H), 2.10--1.97 (m, 1H), 1.83--1.71 (m, 1H), 1.41 (d, *J* = 6.8 Hz, 3H), 0.90 (t, *J* = 7.4 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 165.8, 141.9, 136.3, 129.5, 127.5, 126.9, 126.7, 124.7, 118.7, 37.7, 29.6, 20.1, 12.3; HRMS (ESI): for C~13~H~15~N \[M + H\]^+^ calcd, 186.1282; found, 186.1274.

### 1-(2-Cyclohexylethyl)isoquinoline (**6k**) {#sec4.6.38}

It was obtained as colorless oil; 27.7 mg, 58% yield; *R*~f~ = 0.25 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.42 (d, *J* = 5.7 Hz, 1H), 8.14 (d, *J* = 8.5 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.67--7.62 (m, 1H), 7.60--7.55 (m, 1H), 7.48 (d, *J* = 5.7 Hz, 1H), 3.34--3.26 (m, 2H), 1.92--1.82 (m, 2H), 1.79--1.70 (m, 4H), 1.70--1.62 (m, 1H), 1.49--1.38 (m, 1H), 1.33--1.12 (m, 3H), 1.10--0.96 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 141.9, 136.2, 129.7, 127.3, 126.8, 119.0, 38.1, 37.4, 33.3, 33.1, 26.6, 26.3; HRMS (ESI): for C~17~H~21~N \[M + H\]^+^ calcd, 240.1752; found, 240.1748.

### 1-Benzylisoquinoline (**6l**) {#sec4.6.39}

It was obtained as colorless oil; 10.1 mg, 23% yield; *R*~f~ = 0.35 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.50 (d, *J* = 5.8 Hz, 1H), 8.15 (d, *J* = 8.5 Hz, 1H), 7.81 (d, *J* = 8.2 Hz, 1H), 7.66--7.61 (m, 1H), 7.56 (d, *J* = 5.8 Hz, 1H), 7.53--7.50 (m, 1H), 7.29--7.23 (m, 4H), 7.19--7.14 (m, 1H), 4.68 (s, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 160.1, 141.9, 136.5, 129.8, 128.5, 128.5, 127.3, 127.2, 126.2, 125.8, 119.8, 42.0; HRMS (ESI): for C~16~H~13~N \[M + H\]^+^ calcd, 220.1126; found, 220.1121.

### 1-Phenethylisoquinoline (**6m**) {#sec4.6.40}

It was obtained as yellow oil; 31.2 mg, 67% yield; *R*~f~ = 0.40 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.47 (d, *J* = 5.7 Hz, 1H), 8.14 (d, *J* = 8.5 Hz, 1H), 7.81 (d, *J* = 8.2 Hz, 1H), 7.68--7.63 (m, 1H), 7.60--7.53 (m, 1H), 7.52 (d, *J* = 5.7 Hz, 1H), 7.31 (d, *J* = 4.5 Hz, 4H), 7.25--7.19 (m, 1H), 3.63--3.57 (m, 2H), 3.23--3.17 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 160.9, 141.8, 136.2, 129.8, 128.4, 128.4, 127.3, 127.0, 126.8, 126.0, 125.0, 119.4, 37.1, 35.4; HRMS (ESI): for C~17~H~15~N \[M + H\]^+^ calcd, 234.1282; found, 234.1275.

### 1-(3-Phenylpropyl)isoquinoline (**6n**) {#sec4.6.41}

It was obtained as colorless oil; 22.7 mg, 46% yield; *R*~f~ = 0.33 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.44 (d, *J* = 5.7 Hz, 1H), 8.08--7.99 (m, 1H), 7.79 (s, 1H), 7.67--7.62 (m, 1H), 7.58--7.52 (m, 1H), 7.50 (d, *J* = 5.7 Hz, 1H), 7.32--7.14 (m, 5H), 3.36--3.29 (m, 2H), 2.81 (t, *J* = 7.7 Hz, 2H), 2.27--2.16 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 161.8, 142.0, 141.8, 136.2, 129.7, 128.5, 128.3, 127.3, 126.9, 126.9, 125.8, 125.2, 119.2, 35.9, 34.8, 31.0; HRMS (ESI): for C~18~H~17~N \[M + H\]^+^ calcd, 248.1439; found, 248.1435.

### 1-(But-3-en-1-yl)isoquinoline (**6o**) {#sec4.6.42}

It was obtained as colorless oil; 15.4 mg, 42% yield; *R*~f~ = 0.41 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.44 (d, *J* = 5.7 Hz, 1H), 8.16 (d, *J* = 8.4 Hz, 1H), 7.82 (d, *J* = 8.2 Hz, 1H), 7.71--7.64 (m, 1H), 7.62--7.57 (m, 1H), 7.51 (d, *J* = 5.7 Hz, 1H), 6.05--5.94 (m, 1H), 5.15--5.09 (m, 1H), 5.08--4.97 (m, 1H), 3.45--3.35 (m, 2H), 2.70--2.60 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 161.2, 141.8, 137.9, 136.2, 129.7, 127.4, 127.0, 126.9, 125.1, 119.2, 115.0, 34.6, 33.4; HRMS (ESI): for C~13~H~13~N \[M + H\]^+^ calcd, 184.1126; found, 184.1121.

### 1-(Pent-4-en-1-yl)isoquinoline (**6p**) {#sec4.6.43}

It was obtained as colorless oil; 24.4 mg, 62% yield; *R*~f~ = 0.20 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.44 (d, *J* = 5.8 Hz, 1H), 8.16 (d, *J* = 8.3 Hz, 1H), 7.82 (d, *J* = 8.1 Hz, 1H), 7.72--7.65 (m, 1H), 7.63--7.58 (m, 1H), 7.53 (d, *J* = 5.8 Hz, 1H), 5.95--5.84 (m, 1H), 5.11--4.97 (m, 2H), 3.37--3.28 (m, 2H), 2.25 (q, *J* = 7.2 Hz, 2H), 2.03--1.93 (m, 2H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 161.9, 141.8, 138.3, 136.2, 129.7, 127.3, 126.9, 126.9, 125.2, 119.1, 114.9, 34.7, 33.7, 28.7; HRMS (ESI): for C~14~H~15~N \[M + H\]^+^ calcd, 198.1282; found, 198.1276.

### 1-(Hept-6-en-1-yl)isoquinoline (**6q**) {#sec4.6.44}

It was obtained as colorless oil; 22.0 mg, 49% yield; *R*~f~ = 0.27 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.15 (d, *J* = 8.5 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.69--7.63 (m, 1H), 7.61--7.55 (m, 1H), 7.49 (d, *J* = 5.7 Hz, 1H), 5.87--5.76 (m, 1H), 5.02--4.96 (m, 1H), 4.95--4.90 (m, 1H), 3.33--3.25 (m, 2H), 2.07 (q, *J* = 6.3, 5.6 Hz, 2H), 1.88 (p, *J* = 7.6 Hz, 2H), 1.55--1.43 (m, 4H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 162.2, 141.8, 138.9, 136.2, 129.7, 127.3, 126.9, 126.8, 125.3, 114.2, 35.4, 33.6, 29.5, 29.3, 28.7; HRMS (ESI): for C~16~H~19~N \[M + H\]^+^ calcd, 226.1595; found, 226.1588.

### Ethyl 5-(Isoquinolin-1-yl)pentanoate (**6r**) {#sec4.6.45}

It was obtained as colorless oil; 28.8 mg, 56% yield; *R*~f~ = 0.31 (PE/EA = 2:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.14 (d, *J* = 8.2 Hz, 1H), 7.80 (d, *J* = 8.1 Hz, 1H), 7.69--7.63 (m, 1H), 7.61--7.55 (m, 1H), 7.50 (d, *J* = 5.7 Hz, 1H), 4.12 (q, *J* = 7.1 Hz, 2H), 3.38--3.27 (m, 2H), 2.39 (t, *J* = 7.4 Hz, 2H), 1.99--1.87 (m, 2H), 1.92--1.83 (m, 2H), 1.24 (t, *J* = 7.1 Hz, 3H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 173.5, 161.5, 141.8, 136.1, 129.7, 127.3, 126.9, 126.8, 125.1, 119.2, 77.3, 77.0, 76.6, 34.9, 34.1, 28.8, 25.0, 14.1; HRMS (ESI): for C~16~H~19~NO~2~ \[M + H\]^+^ calcd, 258.1494; found, 258.1491.

### 2-Cyclohexyl-4-methylquinoline (**6s**) {#sec4.6.46}

It was obtained as colorless oil; 34.6 mg, 77% yield; *R*~f~ = 0.45 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.05 (d, *J* = 8.4 Hz, 1H), 7.96--7.90 (m, 1H), 7.69--7.63 (m, 1H), 7.51--7.46 (m, 1H), 7.16 (s, 1H), 2.92--2.84 (m, 1H), 2.70--2.64 (m, 3H), 2.06--1.96 (m, 2H), 1.92--1.86 (m, 2H), 1.82--1.74 (m, 1H), 1.68--1.57 (m, 2H), 1.52--1.41 (m, 2H), 1.39--1.30 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 166.4, 147.5, 129.3, 128.9, 126.9, 125.3, 123.5, 120.1, 47.5, 32.7, 26.5, 26.0, 18.8; HRMS (ESI): for C~16~H~19~N \[M + H\]^+^ calcd, 226.1595; found, 226.1588.

### 4-Chloro-2-cyclohexylquinoline (**6t**) {#sec4.6.47}

It was obtained as colorless oil; 40.2 mg, 82% yield; *R*~f~ = 0.68 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.21--8.15 (m, 1H), 8.05 (d, *J* = 8.4 Hz, 1H), 7.75--7.70 (m, 1H), 7.59--7.54 (m, 1H), 7.42 (s, 1H), 2.93--2.85 (m, 1H), 2.08--1.96 (m, 2H), 2.05--1.87 (m, 2H), 1.84--1.74 (m, 1H), 1.67--1.55 (m, 2H), 1.52--1.40 (m, 2H), 1.38--1.30 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 166.7, 148.6, 142.5, 130.1, 129.2, 126.5, 125.1, 123.8, 119.7, 47.3, 32.6, 26.4, 25.9; HRMS (ESI): for C~15~H~16~ClN \[M + H\]^+^ calcd, 246.1049; found, 246.1043.

### 4-Cyclohexyl-2-methylquinoline (**6u**) {#sec4.6.48}

It was obtained as colorless oil; 24.7 mg, 55% yield; *R*~f~ = 0.32 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.03 (d, *J* = 8.5 Hz, 2H), 7.70--7.60 (m, 1H), 7.52--7.45 (m, 1H), 7.17 (s, 1H), 3.33--3.26 (m, 1H), 2.72 (s, 3H), 2.04--1.87 (m, 4H), 1.85--1.80 (m, 1H), 1.62--1.47 (m, 4H), 1.41--1.28 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 158.7, 153.2, 148.1, 129.5, 128.7, 125.2, 125.1, 122.8, 118.2, 38.7, 33.5, 26.9, 26.3, 25.5; HRMS (ESI): for C~16~H~19~N \[M + H\]^+^ calcd, 226.1595; found, 226.1590.

### 5-Bromo-1-cyclohexylisoquinoline (**6v**) {#sec4.6.49}

It was obtained as colorless oil; 27.7 mg, 48% yield; *R*~f~ = 0.65 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.58 (d, *J* = 5.9 Hz, 1H), 8.21 (d, *J* = 8.6 Hz, 1H), 7.96--7.91 (m, 1H), 7.86 (d, *J* = 5.9 Hz, 1H), 7.46--7.39 (m, 1H), 3.59--3.50 (m, 1H), 2.02--1.89 (m, 4H), 1.88--1.76 (m, 3H), 1.59--1.45 (m, 2H), 1.44--1.32 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 166.0, 143.2, 135.4, 133.3, 127.4, 127.0, 124.4, 122.5, 41.7, 32.6, 26.8, 26.1; HRMS (ESI): for C~15~H~16~BrN \[M + H\]^+^ calcd, 290.0544; found, 290.0543.

### 1-Cyclohexyl-6-methylisoquinoline (**6w**) {#sec4.6.50}

It was obtained as colorless oil; 32.0 mg, 71% yield; *R*~f~ = 0.47 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.43 (d, *J* = 5.7 Hz, 1H), 8.11 (d, *J* = 8.7 Hz, 1H), 7.57 (s, 1H), 7.43--7.36 (m, 2H), 3.56--3.48 (m, 1H), 2.53 (s, 3H), 2.02--1.89 (m, 4H), 1.88--1.73 (m, 3H), 1.62--1.46 (m, 2H), 1.44--1.35 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 165.3, 141.8, 139.7, 136.6, 129.0, 126.4, 124.5, 124.5, 118.4, 41.4, 32.5, 26.8, 26.2, 21.7; HRMS (ESI): for C~16~H~19~N \[M + H\]^+^ calcd, 226.1595; found, 226.1588.

### 2-Cyclohexylquinoxaline (**6x**) {#sec4.6.51}

It was obtained as colorless oil; 29.9 mg, 71% yield; *R*~f~ = 0.37 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.77 (s, 1H), 8.09--8.02 (m, 2H), 7.77--7.66 (m, 2H), 3.03--2.91 (m, 1H), 2.10--2.00 (m, 2H), 1.96--1.90 (m, 2H), 1.84--1.78 (m, 1H), 1.77--1.66 (m, 2H), 1.54--1.42 (m, 2H), 1.42--1.30 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 161.1, 144.9, 142.1, 141.3, 129.7, 129.0, 128.9, 128.8, 45.0, 32.3, 26.3, 25.8; HRMS (ESI): for C~14~H~16~N~2~ \[M + H\]^+^ calcd, 213.1391; found, 213.1386.

### 2-Chloro-3-cyclohexylquinoxaline (**6y**) {#sec4.6.52}

It was obtained as a white solid; 20.2 mg, 41% yield; *R*~f~ = 0.74 (PE/EA = 10:1); mp 94--96 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.08--8.02 (m, 1H), 8.00--7.94 (m, 1H), 7.76--7.67 (m, 2H), 3.39--3.30 (m, 1H), 2.03 (d, *J* = 12.4 Hz, 2H), 1.96--1.90 (m, 2H), 1.86--1.77 (m, 1H), 1.77--1.65 (m, 2H), 1.55--1.43 (m, 2H), 1.42--1.30 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 159.1, 147.4, 141.1, 140.5, 129.8, 128.7, 128.0, 42.5, 31.2, 26.3, 25.9; HRMS (ESI): for C~14~H~15~ClN~2~ \[M + H\]^+^ calcd, 247.1002; found, 247.1002.

### 2-Cyclohexylbenzo\[*d*\]thiazole (**6z**) {#sec4.6.53}

It was obtained as colorless oil; 23.4 mg, 54% yield; *R*~f~ = 0.59 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 7.97 (d, *J* = 8.1 Hz, 1H), 7.85 (d, *J* = 7.9 Hz, 1H), 7.47--7.40 (m, 1H), 7.38--7.29 (m, 1H), 3.15--3.07 (m, 1H), 2.25--2.17 (m, 2H), 1.92--1.86 (m, 2H), 1.82--1.72 (m, 1H), 1.69--1.61 (m, 2H), 1.51--1.39 (m, 2H), 1.38--1.30 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 177.6, 153.0, 134.5, 125.7, 124.4, 122.5, 121.5, 43.4, 33.4, 26.0, 25.7; HRMS (ESI): for C~13~H~15~NS \[M + H\]^+^ calcd, 218.1003; found, 218.0998.

### 5-Cyclohexyl-2,3-diphenylpyrido\[3,4-*b*\]pyrazine (**6aa**) {#sec4.6.54}

It was obtained as a white solid; 60.5 mg, 83% yield; *R*~f~ = 0.25 (PE/EA = 10:1); mp 142--144 °C; ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.74 (d, *J* = 5.8 Hz, 1H), 7.80 (d, *J* = 5.8 Hz, 1H), 7.60--7.51 (m, 4H), 7.43--7.32 (m, 6H), 4.30--4.21 (m, 1H), 2.02 (d, *J* = 13.2 Hz, 2H), 1.97--1.77 (m, 5H), 1.63--1.52 (m, 2H), 1.46--1.34 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 169.4, 156.9, 153.1, 146.3, 143.4, 138.6, 134.0, 129.9, 129.7, 129.3, 128.3, 128.2, 119.2, 39.7, 32.3, 26.6, 26.2; HRMS (ESI): for C~25~H~23~N~3~ \[M + H\]^+^ calcd, 366.1970; found, 366.1964.

### 6-Chloro-7-cyclohexylimidazo\[1,2-*b*\]pyridazine (**6ab**) {#sec4.6.55}

It was obtained as colorless oil; 28.2 mg, 60% yield; *R*~f~ = 0.44 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 7.89 (d, *J* = 1.1 Hz, 1H), 7.72 (d, *J* = 1.1 Hz, 1H), 6.86 (s, 1H), 3.40--3.32 (m, 1H), 2.15--2.02 (m, 2H), 1.90 (dd, *J* = 9.5, 3.1 Hz, 2H), 1.86--1.77 (m, 1H), 1.61--1.44 (m, 4H), 1.37--1.27 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 148.0, 147.3, 137.9, 133.1, 117.1, 114.5, 38.7, 32.0, 26.2, 25.9; HRMS (ESI): for C~12~H~14~ClN~3~ \[M + H\]^+^ calcd, 236.0954; found, 236.0953.

### 2-Cyclohexylisonicotinonitrile (**6ac**) {#sec4.6.56}

It was obtained as colorless oil; 12.6 mg, 34% yield; *R*~f~ = 0.65 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.70 (s, 1H), 7.39 (s, 1H), 7.35--7.33 (m, 1H), 2.81--2.73 (m, 1H), 2.02--1.92 (m, 2H), 1.91--1.85 (m, 2H), 1.81--1.73 (m, 1H), 1.60--1.48 (m, 2H), 1.48--1.36 (m, 2H), 1.34--1.22 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 167.9, 149.9, 122.7, 122.2, 120.4, 116.7, 46.2, 32.4, 26.1, 25.7; HRMS (ESI): for C~12~H~14~N~2~ \[M + H\]^+^ calcd, 187.1235; found, 187.1230.

### 4-Cyclohexylquinazoline (**6ad**) {#sec4.6.57}

It was obtained as colorless oil; 29.9 mg, 46% yield; *R*~f~ = 0.41 (PE/EA = 4:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 9.25 (s, 1H), 8.19 (d, *J* = 8.4 Hz, 1H), 8.04 (d, *J* = 8.4 Hz, 1H), 7.94--7.81 (m, 1H), 7.73--7.56 (m, 1H), 3.60--3.52 (m, 1H), 2.02--1.92 (m, 4H), 1.88--1.76 (m, 3H), 1.59--1.45 (m, 2H), 1.45--1.33 (m, 1H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 175.0, 154.7, 150.0, 133.2, 129.3, 127.2, 124.1, 123.2, 41.2, 32.0, 26.4, 25.9; HRMS (ESI): for C~14~H~16~N~2~ \[M + H\]^+^ calcd, 213.1391; found, 213.1388.

### 2,4-Dicyclohexylquinazoline (**6ad′**) {#sec4.6.58}

It was obtained as colorless oil; 29.9 mg, 20% yield; *R*~f~ = 0.57 (PE/EA = 10:1); ^1^H NMR (400 MHz, CDCl~3~): δ (ppm) 8.11 (d, *J* = 7.9 Hz, 1H), 7.96 (d, *J* = 8.2 Hz, 1H), 7.81--7.75 (m, 1H), 7.54--7.49 (m, 1H), 3.54--3.46 (m, 1H), 3.02--2.94 (m, 1H), 2.10--2.01 (m, 2H), 1.98--1.72 (m, 12H), 1.58--1.32 (m, 6H); ^13^C NMR (100 MHz, CDCl~3~): δ (ppm) 174.4, 170.1, 150.5, 128.8, 125.9, 123.9, 121.3, 47.9, 41.3, 31.9, 31.9, 29.6, 26.5, 26.3, 26.1, 26.0; HRMS (ESI): for C~20~H~26~N~2~ \[M + H\]^+^ calcd, 295.2174; found, 295.2169.

The Supporting Information is available free of charge on the [ACS Publications website](http://pubs.acs.org) at DOI: [10.1021/acsomega.9b01674](http://pubs.acs.org/doi/abs/10.1021/acsomega.9b01674).Optimization of reaction conditions, HRMS spectra for radical trapping experiments, fluorescence quenching curves, CV curves of substrates, determination of quantum yields, ^1^H NMR and ^13^C NMR spectra for all products ([PDF](http://pubs.acs.org/doi/suppl/10.1021/acsomega.9b01674/suppl_file/ao9b01674_si_001.pdf))
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